ALKERMES | Försäljning



Sales Ändra Datum
AbbVie USD 15.1B 642M 2024-12
Acadia Pharmaceuticals USD 259.6M 9.2M 2024-12
ALKERMES USD 430M 51.9M 2024-12
Amgen USD 9.09B 583M 2024-12
Biogen USD 2.45B 11.1M 2024-12
BioMarin Pharmaceutical USD 747.31M 1.57M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
Gilead Sciences USD 7.57B 24M 2024-12
Ionis Pharmaceuticals USD 226.58M 92.76M 2024-12
J&J USD 22.52B 49M 2024-12
Malin Corporation EUR 19.2M 2.6M 2020-12
Merck USD 15.62B 1.03B 2024-12
Neurocrine Biosciences USD 627.7M 5.6M 2024-12
Otsuka Holdings JPY 599.79B 21.36B 2024-12
Pfizer USD 17.76B 61M 2024-12
Regeneron Pharmaceuticals USD 3.79B 70M 2024-12
Vertex Pharmaceuticals USD 2.91B 140.1M 2024-12



ALKERMES Försäljning - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.